Immune-suppressing drugs and booster vaccination

Interrupting treatment of immune-suppressing medicines, doubles antibody response to COVID-19 booster vaccination: A major clinical trial, led by experts at the University of Nottingham working...

T cells a key defence against Omicron

T cells a key defence against Omicron: Research from the University of Melbourne and Hong Kong University of Science and Technology (HKUST) has revealed T cells, one...

WHO: Classification of Omicron Variant of Concern

WHO Statement ​-- Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of...